Volume 2, Issue 3

Jeetu G, Anusha G

pp. 315–320 · DOI: 10.4103/0975-1483.66802

Pharmacovigilance is like a sunshade to describe the processes for monitoring and evaluating ADRs and it is a key component of effective drug regulation systems, clinical practice and public health programmes. The number…

Anand K, Saini KS, Chopra Y, Binod SK

pp. 321–325 · DOI: 10.4103/0975-1483.66804

‘Medical Devices’ include everything from highly sophisticated, computerized, medical equipment, right down to simple wooden tongue depressors. Regulations embody the public expectations for how buildings and facilities …

Ansari JA

pp. 326–331 · DOI: 10.4103/0975-1483.66807

The topic of drug–drug interactions has received a great deal of recent attention from the regulatory, scientific, and health care communities worldwide. Nonsteroidal anti-inflammatory drugs, antibiotics and, in particul…

Attarwala H

pp. 332–336 · DOI: 10.4103/0975-1483.66810

After a drug is confirmed as safe and efficacious in preclinical studies, it is tested in healthy human volunteers for first in man trials. In 2006, a phase I clinical study was conducted for a CD28 superagonist antibody…

Jain R, Kosta S, Tiwari A

pp. 337

Sir, Urinary tract infections (UTIs), the second most common type of infection in the body is one the most serious health problem affecting millions of people each year. The urinary tract infection (UTI) involves infecti…